Hippe, D. S., Phan, B. P., Sun, J., Isquith, D. A., O’Brien, K. D., Crouse, J. R., . . . Zhao, X. (2018). Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy—Brief Report. Arteriosclerosis, thrombosis, and vascular biology, 38(3), 673-678. https://doi.org/10.1161/ATVBAHA.117.310368
Chicago Style (17th ed.) CitationHippe, Daniel S., et al. "Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy—Brief Report." Arteriosclerosis, Thrombosis, and Vascular Biology 38, no. 3 (2018): 673-678. https://doi.org/10.1161/ATVBAHA.117.310368.
MLA (9th ed.) CitationHippe, Daniel S., et al. "Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy—Brief Report." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 38, no. 3, 2018, pp. 673-678, https://doi.org/10.1161/ATVBAHA.117.310368.